You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers in the UK are building a database of dog DNA to uncover inherited disease among dog breeds with low numbers, Wired UK reports.
In PLOS this week: Aedes aegypti and Ae. albopictus mosquito population genomics, strategies to profile hepatitis viruses, and more.
The PCR test detects HIV-1 RNA on the NeuMoDx 96/288 Molecular Systems and joins the company's other bloodborne viral tests for hepatitis B and C.
The test will be included in the World Health Organizations list of prequalified in vitro diagnostics and UN agencies will be able to procure it.
According to New Scientist, the transatlantic slave trade may have introduced diseases like yaws and hepatitis B to the Americas.
The test is the second infectious disease assay from Bioneer to be CE marked, and the South Korean company has a third test in the pipeline.
The assay is based on the company's AmpiProbe technology, which uses fluorescent reporter-labeled primers and quencher-labeled primers to amplify DNA.
In PLOS this week: reference bias effects in ancient genomics, tsetse fly genetic diversity, and more.
In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.
Abbott said that the MDx platform offers a number of initial assays, including tests for HIV-1, HBV, and HCV, among others.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.
